Skip to content
Open access · OA via OpenAlex

Targeting cellular senescence as a novel treatment for osteoarthritis

Emma M. Astrike‐Davis, Philip Coryell, Richard F. Loeser

Current Opinion in Pharmacology · 2022 · ▲ 52 citations

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.coph.2022.102213
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Astrike‐Davis, E.M., Coryell, P., &amp; Loeser, R.F. (2022). Targeting cellular senescence as a novel treatment for osteoarthritis. <em>Current Opinion in Pharmacology</em>. https://doi.org/10.1016/j.coph.2022.102213
Vancouver
Astrike‐Davis EM, Coryell P, Loeser RF. Targeting cellular senescence as a novel treatment for osteoarthritis. Current Opinion in Pharmacology. 2022. doi:10.1016/j.coph.2022.102213.
BibTeX
@article{emma2022Target, title = {Targeting cellular senescence as a novel treatment for osteoarthritis}, author = {Emma M. Astrike‐Davis and Philip Coryell and Richard F. Loeser}, journal = {Current Opinion in Pharmacology}, year = {2022}, doi = {10.1016/j.coph.2022.102213}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings